Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00598065 · ClinicalTrials.gov registry record · NA

The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT00598065: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00598065 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00598065, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The purpose of this study is to see if researchers can improve the detection of lung cancer by using a new method which will help us to take multiple snapshot images of the lungs while the patient is breathing. We are also investigating whether with the help of this new method we can better measure the actual amount of radioactivity that is taken up by the cancer. The name of this new method is respiratory gated PET/CT. Previous research has shown that PET scans may be useful in investigating whether cancer has spread to other parts of the lung or body. Using our standard method, smaller cancers are sometimes difficult to detect in the lungs because the PET images are taken over several minutes and the patient is breathing during that time. That means the cancer may appear "blurred" on the images (like a poor photograph) or may not be identified at all. In this study, in addition to the images that were ordered by your doctor, we will take additional images of your lungs while you are following a breathing command ("breath in-hold-breath out"). We will then compare the images of your cancer during the regular PET study with those taken during the breathing commands. The hypotheses to be tested in this pilot study are: 1. Respiratory gated image acquisition reduces partial volume effects on PET image that may render lung lesions undetectable. 2. Breath-hold CT may detect small lung lesions that are beyond the limit of detection in shallow-breathing CT scans, related to respiratory motion which causes blurring artifacts around smaller lung lesions.

Interventions

  • OTHER PET/CT

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2004-03
Est. Completion 2009-12
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00598065

The ClinicalTrials.gov registry entry for NCT00598065 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PET/CT is the first listed.

NCT00598065 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00598065 about?

NCT00598065 is a clinical study titled "The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules". The purpose of this study is to see if researchers can improve the detection of lung cancer by using a new method which will help us to take multiple snapshot images of the lungs while the patient is breathing. We are also investigating whether with the help of this new method we can better measure ...

What is the current status of trial NCT00598065?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2004-03. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00598065?

The interventions under investigation include: PET/CT (OTHER).

Who is sponsoring clinical trial NCT00598065?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.